PPT-CV Outcomes and Adherence

Author : ellena-manuel | Published Date : 2019-02-05

With GLP1 RAs This program will include a discussion of investigational agents not approved by the FDA for use in the United States and data that were presented

Presentation Embed Code

Download Presentation

Download Presentation The PPT/PDF document "CV Outcomes and Adherence" is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.

CV Outcomes and Adherence: Transcript

With GLP1 RAs This program will include a discussion of investigational agents not approved by the FDA for use in the United States and data that were presented in abstract form These data should be considered preliminary until published in a . Meck Chongo, . Virginia . Russell, . Josée. Lavoie, Ross Hoffman, . Mamdouh. . Shubair. University of Northern British Columbia. Agenda. . Background. Objectives . Participants & Research Environment. Reasons why patients do not adhere. Measuring adherence and non adherence. Improving adherence. Reasons for non-adherence: cognitive rational non-adherence. Adherence is all about being conscientious in following medical advice. . Ronni. AW Wetmore, RN, MS. Coordinator, Stanford Adult Cystic Fibrosis Center. Speaker Bureau: . Chiesi. Pharmaceuticals. Nurse Advisory Board: Genentech Pharmaceutical Company. Nurse Advisory Board: Gilead Pharmaceutical. Doyle M. Cummings, PharmD, FCP, FCCP. Professor of Family Medicine and Public Health. East Carolina University, Brody School of Medicine. Greenville, North Carolina. . [Residency educators may . adapt and use . Jessica Haberer, MD, MS. July . 24, . 2017. Conflicts of Interest. I have no conflicts to declare. Grant funding: US National Institutes of Health, Bill and Melinda Gates Foundation, USAID. Consultation: US National Institutes of Health, World Health Organization, Merck. Angelica Lindsey-Ali & Calicia White. Ebony House Inc.. Objectives. By the end of this section, participants should be able to. : . Understand the difference between cultural humility and cultural competence. Oral . PrEP. in MSM. Division of Global HIV and TB, CDC, New Delhi, India. Timothy H. . Holtz . (CDC/DHAP / Thailand MOPH – US CDC Collaboration). and HPTN . 067/ADAPT Study . Team. MOSY08, IAS. , . scenario in Nepal. Presentation By. :. Ms. Niru Khatiwada. BSc Nursing (BPKIHS), MN (IOM, TU). Lecturer, Nepal Medical College . (Affiliated to Kathmandu University). Kathmandu, Nepal. 1. OVERVIEW. OVERVIEW. Janice M. . Bissonnette. Journal of Advanced Nursing. 63(6), 634-643. Nursing 8440. October 15, 2012. Jennifer Bauman, RN, BA, PCCN. Background. 2003 WHO initiative to improve rates of adherence to therapies for chronic conditions . P1115 . Zimbabwe. , Harare Family . Care Experience. T . P. MHEMBERE: BSc Pharm Hons (. Z. im), MPH (UK). Potential Conflicts and Financial Disclosure. I have no actual or potential conflicts . to . declare in relation to this presentation.. Patients do . not. take their medicine . as prescribed. about . half. the time. . 2. Why is it important to assess adherence?. =. 3. 4. Eight. . steps to . improve medication adherence. in . your. Hypertension. A Major Public Health Crisis. 20-Year Trends in Hypertension in the US. 1988–2008. Hypertension. African Americans. Contrasts in Goal BP Recommendations. Systolic Blood Pressure Intervention Trial (SPRINT). Team Members. Michael Ingram Jr, Heather Makwinski, Joshua Michalik, Samantha Taylor Talarico. 0. 2. 03. 01. BACKGROUND: The Business Case. Health Insurance. Companies. Medication non-adherence can have negative implications for the patient, the doctor/hospital, and insurance company.. Conversation & Controversy in Immunosuppression. ENV-17-038.0. Definition and components of medication adherence. Trends and rates of adherence among different subgroups. Impact of adherence on kidney transplant recipients.

Download Document

Here is the link to download the presentation.
"CV Outcomes and Adherence"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.